Faculty profile

Elaine Yacyshyn

Back to faculty

ProfessorMedicine DeptUniversity of Alberta

Elaine Yacyshyn

Professor

Medicine Dept

Faculty of Medicine & Dentistry

University of Alberta

Edmonton, Alberta, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
30 publications in the last five years, latest in 2026.
Senior (last) author on 12 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

529

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Alberta profile.

Latest papers

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross-Sectional Survey Data.
Arthritis care & research · 2026
Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study
JMIR Research Protocols · 2026
Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study
ACR Open Rheumatology · 2026

All 58 publications

Latest funding

Implementing Electronic Health Record-based social determinants of health risk factor screening and intervention in rheumatology care
CIHR · 2026 · Co-investigator
$348,074
Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot
CIHR · 2023 · Co-investigator
$520,200
Implementation of the Alberta Rheumatology Provincial Learning Health System
CIHR · 2022 · Co-investigator
$313,649

All 5 grants and awards

58 publications.

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross-Sectional Survey Data.

Zhang S, Lowe SAJ, Sun F, Jones A, Turk T, Olson J, Paul P, Yamamoto S, Kolewaski L, Yacyshyn E, Sadowski CA

Arthritis care & research2026Open Access

DOI: 10.1002/acr.80071 PMID: 42045789

Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study

Heba A T Aref, Yazid N. Al Hamarneh, Tony K L Kiang, Elaine Yacyshyn, Cheryl A Sadowski

JMIR Research Protocols2026Open Access

DOI: 10.2196/76237 PMID: 41911387

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study

Mendel A, Barra L, Behlouli H, Bernatsky S, Clifford AH, Tervaert JWC, Dehghan N, Fifi‐Mah A, Makhzoum J, Meunier R

ACR Open Rheumatology2026Open Access

DOI: 10.1002/acr2.90119

Exploring Clinicians' Determinants of Participation in Medical Cannabis Decision Making with Older Adults Experiencing Arthritis: A Qualitative Descriptive Study.

Aref HAT, Al Hamarneh YN, Yacyshyn E, Kiang TKL, Sadowski CA

MDM policy & practice2026

DOI: 10.1177/23814683261444057 PMID: 42181610

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis

Langford CA, Khalidi N, Springer J, Friedman M, Hellmich B, Pagnoux C, Dehghan N, Gewurz‐Singer O, Koening CL, Lin YC

Arthritis & Rheumatology202514 citationsOpen Access

DOI: 10.1002/art.43272

Comparison of [18F]fluorodeoxyglucose and [68Ga]Gallium DOTA-TATE in patients with active giant cell arteritis.

Clifford AH, Abele J, Hung R, Wuest F, Andersson J, Pike S, Yacyshyn E, Lenza E, Jickling G, Raggi P, Cohen Tervaert JW

EJNMMI reports20253 citationsOpen Access

DOI: 10.1186/s41824-025-00242-y PMID: 40021570

Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report.

Ramadhan A, Troug A, Yacyshyn E, Gniadecki R

SAGE open medical case reports20253 citationsOpen Access

DOI: 10.1177/2050313x251350376 PMID: 40589849

Imaging in clinical trials for psoriatic arthritis: a scoping review.

Xiao A, Roy A, Dennett L, Yacyshyn E, Li MD

Skeletal radiology20251 citations

DOI: 10.1007/s00256-025-04884-8 PMID: 39912887

Navigating the Roadblocks: National Patient and Provider Survey on Barriers to Healthcare and Medication Access for Patients With Vasculitis

Kareena Nanda, Pamela V. Mathura, Katharina Kovacs Burns, Christian Pagnoux, Jon Stewart, Elaine Yacyshyn

The Journal of Rheumatology2025Senior author

DOI: 10.3899/jrheum.2025-0640 PMID: 41033826

The development of a cannabis risk assessment tool for patients with rheumatologic conditions: a Delphi study

Tarek Turk, Kaitlyn E. Watson, Heba A. T. Aref, Dimple Patel, C Allyson Jones, Joanne Olson, Pauline Paul, Cheryl A Sadowski, Elaine Yacyshyn

Clinical Rheumatology2025Senior author

DOI: 10.1007/s10067-025-07807-z PMID: 41345331

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Elaine Yacyshyn

Research

Latest papers

Latest funding

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in&#xa0;Alberta, Canada: A Multivariable Analysis of Cross-Sectional Survey Data.

Development of a Decision Aid to Support Shared Decision-Making on Cannabis Use for Arthritis: Protocol for a Multiphase Study

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study

Exploring Clinicians' Determinants of Participation in Medical Cannabis Decision Making with Older Adults Experiencing Arthritis: A Qualitative Descriptive Study.

A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis

Comparison of [18F]fluorodeoxyglucose and [68Ga]Gallium DOTA-TATE in patients with active giant cell arteritis.

Successful use of anifrolumab in refractory cutaneous lupus erythematosus with systemic lupus erythematosus: A case report.

Imaging in clinical trials for psoriatic arthritis: a scoping review.

Navigating the Roadblocks: National Patient and Provider Survey on Barriers to Healthcare and Medication Access for Patients With Vasculitis

The development of a cannabis risk assessment tool for patients with rheumatologic conditions: a Delphi study

Implementing Electronic Health Record-based social determinants of health risk factor screening and intervention in rheumatology care

Glucocorticoids or Avacopan in peopLe with high-risk renal Anti-Neutrophil cytoplasm antibody associated vasculitis Trial (GALANT) - Pilot

Implementation of the Alberta Rheumatology Provincial Learning Health System

Building a network and program of research excellence to tackle arthritis in Canada, China, England and India: Focusing on low- and middle-income and immigrant populations

ANSWER-2: A biologic decision aid for patients with rheumatoid arthritis

Frequent collaborators

Christian Pagnoux

Nader Khalidi

Nataliya Milman

Lillian Barra

Marinka Twilt

David Cabral

Mohammed Osman

Leilani Famorca

Susanne Benseler

Pauline Paul

Alison Clifford

Joanne Olson

Robert Gniadecki

Katharina Kovacs Burns

Cheryl Sadowski

Heather Reich

Regina Taylor-Gjevre

Allyson Jones

Jean-Paul Makhzoum

Gerard Cox

Giovanni Ferrara

Shelby Yamamoto

Arielle Mendel

Marie Clements-Baker

Medha Soowamber

Derek Emery

Alfred Cividino

Elena Netchiporouk

Diane Lacaille

Chris Shaw

Tanveer Towheed

Justin Smith

Damien Noone

Matthew Li

Narmin Kassam

Caylea Foster

Perceived Impacts and Predictors of Cannabis Products Used by Patients with Rheumatologic Conditions in Alberta, Canada: A Multivariable Analysis of Cross-Sectional Survey Data.